MedPath

Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis

Not Applicable
Conditions
Chronic Sinusitis
Interventions
Device: Saline irrigation
Device: Photodisinfection (antimicrobial photodynamic therapy, aPDT)
Registration Number
NCT01854619
Lead Sponsor
Ondine Biomedical Inc.
Brief Summary

The purpose of this study is to determine whether the use of light and a topically applied photosensitizer can relieve symptoms and clinically improve patients with chronic rhinosinusitis.

Detailed Description

This clinical trial will be a prospective, randomized, single-center study utilizing two treatment assignments and a control group. The study is expected to enroll a total of 48 subjects. The intent of the study is to evaluate a single versus double treatment of photodisinfection in men and women suffering from chronic persistent rhinosinusitis with and without nasal polyposis. Each photodisinfection treatment group will be compared to a control group receiving saline irrigation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
48
Inclusion Criteria
  • history of chronic rhinosinusitis with and without nasal polyposis
  • no antibiotics within 4 weeks
  • no oral steroid use within 4 weeks
  • no topical steroid use within 2 weeks
  • endoscopic sinus surgery greater than 6 months previously
Exclusion Criteria
  • acute respiratory infection within last 2 weeks
  • septal deviation restricting sinus access
  • known allergy to methylene blue
  • pregnant or breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Saline irrigationSaline irrigationSaline irrigation via syringe will be administered using a sinus irrigation catheter under endoscopic control.
Double photodisinfection treatmentPhotodisinfection (antimicrobial photodynamic therapy, aPDT)Patients in the double treatment arm will receive a second photodisinfection treatment 4 weeks following the first treatment with regular follow-up visits
Single photodisinfection treatmentPhotodisinfection (antimicrobial photodynamic therapy, aPDT)The single-treatment group will receive a single photodisinfection treatment of all involved paranasal sinuses with multiple follow-up visits.
Primary Outcome Measures
NameTimeMethod
SNOT-226 months

The Sino-Nasal Outcome Test (SNOT-22) has been widely adopted in clinical practice and has been proved to be the most suitable and validated sinonasal outcome scoring system. The SNOT-22 is a disease-specific, quality-of-life-related measure of sinonasal function. Low score indicates good outcome.

Secondary Outcome Measures
NameTimeMethod
Microbiome evaluation6 months

Microbiological conventional cultures, gene expression profiling and microbiome profiling by 16s RNA.

Trial Locations

Locations (1)

Centre hospitalier de l'UdeM (CHUM)

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath